首页股票行情数据研报基金债券期指期货期权黄金外汇银行
当前位置：首页 - 行情中心 - 联亚药业(301569) - 财务分析

联亚药业

(301569)

  

流通市值：24.67亿  总市值：188.22亿
流通股本：1.17亿   总股本：8.92亿

联亚药业(301569)财务分析

返回个股资料首页>>

财务报表

主要指标 利润表 资产负债表 现金流量表 业绩预告
利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入746,953,750.18491,831,812.75234,677,000895,470,048.65
营业总成本495,117,852.61323,570,067.89-616,368,836.41
其他经营收益
营业利润257,199,587.75164,172,332.5373,153,800262,832,229.95
利润总额257,381,330.08164,359,529.5673,284,200263,132,532.16
净利润226,409,503.37141,027,688.95-227,819,038.04
每股收益
其他综合收益-920,957.21-681,513.46--488,396.77
综合收益总额225,488,546.16140,346,175.49-227,330,641.27
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计1,862,857,873.21,753,931,477.68-1,618,746,549.07
非流动资产:
非流动资产合计670,195,945.59675,083,874.11-675,104,154.05
资产总计2,533,053,818.792,429,015,351.792,340,071,2002,293,850,703.12
流动负债:
流动负债合计139,243,182.35133,757,828.77-166,642,364.64
非流动负债:
非流动负债合计112,681,950.98114,660,394.2-117,213,380.45
负债合计251,925,133.33248,418,222.97252,144,300283,855,745.09
所有者权益(或股东权益):
归属于母公司股东权益合计2,281,128,685.462,180,597,128.822,087,926,8002,009,994,958.03
股东权益合计2,281,128,685.462,180,597,128.82-2,009,994,958.03
负债和股东权益合计2,533,053,818.792,429,015,351.79-2,293,850,703.12
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计769,984,137.32520,607,883.71-903,225,586.73
经营活动现金流出小计486,173,313.01317,251,181.97-580,647,004.32
经营活动产生的现金流量净额283,810,824.31203,356,701.74112,550,500322,578,582.41
投资活动产生的现金流量:
投资活动现金流入小计3,417,051,967.822,172,219,633.52-3,616,618,641.35
投资活动现金流出小计3,785,134,689.952,453,083,859.68-3,858,859,423.55
投资活动产生的现金流量净额-368,082,722.13-280,864,226.16--242,240,782.2
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计1,642,923.931,537,830-72,703,129.3
筹资活动产生的现金流量净额-1,642,923.93-1,537,830--72,703,129.3
汇率变动对现金及现金等价物的影响-19,471,164.06-15,401,271.61--18,271,678
现金及现金等价物净增加额-105,385,985.81-94,446,626.03--10,637,007.09
期末现金及现金等价物余额117,722,504.27128,661,864.05-223,108,490.08
补充资料:
现金及现金等价物的净增加额--94,446,626.03--10,637,007.09
TOP↑